AOL Money & Finance

DrPepperSnapple posts

Feed

Dr Pepper up on Q2 report

Dr Pepper Snapple Group (NYSE: DPS) is having one refreshing day so far. At the time of this writing, shares of the beverage entity were up over 5%, with volume being quite strong. Dr Pepper delivered a decent Q2 report that surprised the experts on Wall Street, so the market was happy to extend a little buying interest.

According to the preview, Dr Pepper was supposed to do $1.5 billion on the top line and 49 cents on the bottom line. Net sales roughly matched the estimate, but net income went way beyond the call. Dr Pepper made 62 cents per share on an adjusted basis.

Continue reading Dr Pepper up on Q2 report

Dr Pepper beats the analysts in Q1

Dr Pepper Snapple Group (NYSE: DPS) popped open its first-quarter report on Wednesday (I bet you never read that pun before from a financial pundit covering a beverage concern!). On an adjusted basis, sales rose 4%. Management needed to adjust for the termination of a contract with Hansen (NASDAQ: HANS), as well as for currency effects. The company saw a drop in bottom-line income excluding items as earnings came in at $0.37 per share. This was $0.03 less than last year's performance.

However, Dr Pepper can feel happy about the fact that the company beat expectations. The market was only looking for $0.29 per share. How refreshing (yep, another pun)! Volumes did all right during the quarter.

Continue reading Dr Pepper beats the analysts in Q1

Analyst initiations: MHP, CRIS, DPS, CQB, IRM and AZDDF

MOST NOTEWORTHY: McGraw-Hill, Curis and Azure Dynamics were today's noteworthy initiations:
  • Jefferies initiated McGraw-Hill (NYSE: MHP) with a Buy rating and $49 target. The firm believes the downturn in credit markets has already been fully priced into shares and expects the stock to gain momentum throughout 2008 in anticipation of liquidity returning to credit markets.
  • RBC Capital initiated Curis (NASDAQ: CRIS) with an Outperform rating and $2.50 target based on the company's partnership with Genentech (NYSE: DNA) and potential upside from its pipeline.
  • Merriman started Azure Dynamics (OTC: AZDDF) with a Buy rating. The firm believes the company's focus is where customers see the most benefit from a medium-duty hybrid or market-appropriate solutions and finds the stock attractively valued.
OTHER INITIATIONS:

Analyst initiations: LTRE, SDTH and CPHD

MOST NOTEWORTHY: Learning Tree, Shengdatech and Cepheid were today's noteworthy initiations:
  • B. Riley initiated Learning Tree (NASDAQ:LTRE) with a Buy rating and $24 target. The firm believes investors have an opportunity to invest in a compelling revenue growth/margin expansion story at reasonable multiples with the stock off recent highs.
  • Merriman started Shengda Tech (NASDAQ:SDTH) with a Buy rating and points to the company's growing nano-particle business and the vast market expansion opportunities associated with this business.
  • Stephens believes Cepheid (NASDAQ:CPHD) possesses a best-in-class platform for molecular diagnostic testing with a virtual monopoly in the molecular point of care market; shares were assumed with an Overweight rating and $32 target.
OTHER INITIATIONS:
  • Visa (NYSE:V) was started at Morgan Keegan with a Market Perform rating.
  • Morgan Stanley initiated Dr. Pepper Snapple (N YSE:DPS) with an Equal Weight rating and $30 target.
  • Goldman initiated Kraft Foods (NYSE:KFT) with a Neutral rating.

Symbol Lookup
IndexesChangePrice
DJIA+3.7110,437.42
NASDAQ+4.622,173.80
S&P 500+0.661,106.31

Last updated: November 25, 2009: 09:40 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance